Sab Biotherapeutics Inc (SABS)

Sab Biotherapeutics Inc Azioni (SABS) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
	10.79%25.90	23.38	20.00	15.77	12.68
Research and Development	11.78%18.08	16.17	13.40	10.73	8.97
Operating Income/Loss	10.79%-25.90	-23.38	-20.00	-15.77	-12.68
Net Interest Income/Expense	1.61	-	-	-	-
Nonoperating Income/Loss	306.21%3.60	0.89	1.13	-1.09	58.12
	0.85%-22.30	-22.49	-18.87	-16.86	45.45
Attributable To Parent	0.85%-22.30	-22.49	-18.87	-16.86	45.45
Available To Common Stockholders, Basic	0.85%-22.30	-22.49	-18.87	-2.85	5.34
Basic Average Shares	16.91%93.24	79.75	53.56	9.56	10.66
Diluted Average Shares	16.91%93.24	79.75	53.56	31.04	77.86
Basic Earnings Per Share	14.29%-0.24	-0.28	-0.35	-0.51	0.50
Diluted Earnings Per Share	14.29%-0.24	-0.28	-0.35	-0.46	-0.21
Undistributed Earnings/Loss Allocated To Participating Securities, Basic	-	-	-	-14.02	40.11